Related Experiment Video
Updated: Aug 9, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Inhibition of morphological transformation of C3H10T1/2CL8 mouse embryo cells by multiple carcinogen treatments
S Nesnow1, H Garland, G Curtis
1Carcinogenesis and Metabolism Branch, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711.
Abstract:
C3H10T1/2CL8 cells treated on the first day after seeding with benzo[a]pyrene (B[a]P) and then treated again with B[a]P displayed an inhibited response of morphological transformation if the second treatment was administered from 14 days to 33 days after seeding. Under these conditions the cells exhibited up to 100% inhibition of morphological transformation, the extent of inhibition being related to the concentration of B[a]P administered in the second treatment. 3-Methylcholanthrene (3MC) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) also inhibited B[a]P-induced morphological transformation as a function of concentration when administered to cells 21 days after the initial B[a]P treatment. Delayed recovery of transformed foci was examined in cells treated with B[a]P on days 1 and 22 and scored 6-9 weeks after the first B[a]P treatment. No recovery of cell transformants was observed. Reconstruction experiments with normal and transformed C3H10T1/2CL8 cells suggested that selective cytotoxicity to incipient transformed cells could account for the inhibition by MNNG, but could not account for up to 50% of the inhibition induced by the second treatment of B[a]P or 3MC.
Insights
Delayed benzo[a]pyrene (B[a]P) re-treatment of C3H10T1/2CL8 cells significantly inhibited morphological transformation. This inhibition, dose-dependent, suggests a novel mechanism beyond cytotoxicity for B[a]P and 3-methylcholanthrene (3MC).
Area of Science:
- Cell biology
- Chemical carcinogenesis
- Toxicology
Background:
- Benzo[a]pyrene (B[a]P) is a known carcinogen that induces morphological transformation in C3H10T1/2CL8 cells.
- Understanding the mechanisms of chemical carcinogenesis and potential interventions is crucial for cancer prevention.
Purpose of the Study:
- To investigate the effect of delayed secondary treatments with B[a]P, 3-methylcholanthrene (3MC), and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) on B[a]P-induced cell transformation.
- To explore the mechanisms underlying the observed inhibition of transformation.
Main Methods:
- C3H10T1/2CL8 cells were treated with B[a]P on day 1, followed by a second treatment with B[a]P, 3MC, or MNNG at later time points (14-33 days).
- Morphological transformation was assessed, and inhibition was quantified.
- Reconstruction experiments were performed using normal and transformed cells to evaluate the role of selective cytotoxicity.
Main Results:
- Delayed secondary treatments with B[a]P (14-33 days post-seeding) resulted in up to 100% inhibition of morphological transformation, dependent on B[a]P concentration.
- 3MC and MNNG also inhibited B[a]P-induced transformation when administered 21 days after the initial B[a]P treatment.
- Selective cytotoxicity could explain MNNG-induced inhibition but not the inhibition observed with secondary B[a]P or 3MC treatments.
Conclusions:
- Delayed re-treatment with B[a]P or 3MC can effectively inhibit chemical-induced cell transformation.
- The inhibitory mechanism of B[a]P and 3MC appears to involve factors beyond selective killing of transformed cells.
- These findings suggest potential strategies for modulating chemical carcinogenesis.
Related Concept Videos
In-vitro Mutagenesis
Mutagenicity and Carcinogenicity

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)